Biology of peripheral blood cells in obstructive sleep apnea - The tip of the iceberg

Archives of Physiology and Biochemistry

Volumn 114, Issue 4, 2008, Pages 244-254

  Lavie, Lena ^a   Dyugovskaya, Larissa ^a   Polyakov, Andrey ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Endothelial cells; Erythrocytes; Inflammation; Leukocytes; Obstructive sleep apnea; Platelets

Indexed keywords

CYTOKINE; OXYGEN;

ANOXIA; ATHEROSCLEROSIS; BIOLOGICAL MODEL; BLOOD; BLOOD CELL; CARDIOVASCULAR DISEASE; CELL ADHESION; CYTOLOGY; ENDOTHELIUM CELL; ERYTHROCYTE; HUMAN; INFLAMMATION; LEUKOCYTE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; RISK FACTOR; SLEEP APNEA SYNDROME;

ANOXIA; ATHEROSCLEROSIS; BLOOD CELLS; CARDIOVASCULAR DISEASES; CELL ADHESION; CYTOKINES; ENDOTHELIAL CELLS; ERYTHROCYTES; HUMANS; INFLAMMATION; LEUKOCYTES; MODELS, BIOLOGICAL; OXYGEN; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE;

EID: 54349121592     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.1080/13813450802306701     Document Type: Review

References (109)

1. Anstead M, Phillips B. 1999. The spectrum of sleep-disordered breathing. Respir Care Clin N Am 5:363-77, viii.
2. Basta M, Vgontzas AN. 2007. Metabolic abnormalities in obesity and sleep apnea are in a continuum. Sleep Med 8:5-7.
3. Bazzano LA, Khan Z, Reynolds K, He J. 2007. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension 50:417-23.
4. Bixler EO, Vgontzas AN, Lin HM, Ten Have T, Leiby BE, Vela-Bueno A, Kales A. 2000. Association of hypertension and sleep-disordered breathing. Arch Intern Med 160:2289-95.
5. Bokinsky G, Miller M, Ault K, Husband P, Mitchell J. 1995. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation. Chest 108:625-30.
6. Carlson JT, Hedner J, Elam M, Ejnell H, Sellgren J, Wallin BG. 1993. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 103:1763-8.
7. Charuzi I, Ovnat A, Peiser J, Saltz H, Weitzman S, Lavie P. 1985. The effect of surgical weight reduction on sleep quality in obesity-related sleep apnea syndrome. Surgery 97:535-8.
8. Chin K, Nakamura T, Shimizu K, Mishima M, Nakamura T, Miyasaka M, Ohi M. 2000. Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 109:562-7.
9. Constantinidis J, Ereliadis S, Angouridakis N, Konstantinidis I, Vital V, Angouridaki C. 2008. Cytokine changes after surgical treatment of obstructive sleep apnea syndrome. Eur Arch Otorhinolaryngol [Epub ahead of print], PMID: 18317790.
10. Davignon J, Ganz P. 2004. Role of endothelial dysfunction in atherosclerosis. Circulation 109(23 Suppl 1):III27-32.
11. Drager LF, Bortolotto LA, Figueiredo AC, Krieger EM, Lorenzi-Filho G. 2007. Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 176:706-12.
12. Drager LF, Bortolotto LA, Lorenzi MC, Figueiredo AC, Krieger EM, Lorenzi-Filho G. 2005. Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172:613-8.
13. Dyugovskaya L, Lavie P, Hirsh M, Lavie L. 2005a. Activated CD8+ T-lymphocytes in obstructive sleep apnea. Eur Respir J 25:820-8.
14. Dyugovskaya L, Lavie P, Lavie L. 2002. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165:934-9.
15. Dyugovskaya L, Lavie P, Lavie L. 2003. Phenotypic and functional characterization of blood gammadelta T cells in sleep apnea. Am J Respir Crit Care Med 168:242-9, 66.
16. Dyugovskaya L, Lavie P, Lavie L. 2005b. Lymphocyte activation as a possible measure of atherosclerotic risk in patients with sleep apnea. Ann NY Acad Sci 1051:340-50.
17. Dyugovskaya L, Polyakov A, Lavie P, Lavie L. 2008. Delayed neutrophil apoptosis in sleep apnea patients. Am J Respir Crit Care Med 177:544-54.
18. Eisensehr I, Ehrenberg BL, Noachtar S, Korbett K, Byrne A, McAuley A, Palabrica T. 1998. Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome. Neurology 51:188-95.
19. Friedlander AH, Yueh R, Littner MR. 1998. The prevalence of calcified carotid artery atheromas in patients with obstructive sleep apnea syndrome. J Oral Maxillofac Surg 56:950-4.
20. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. 2004. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114:1752-61.
21. Gavins F, Yilmaz G, Granger DN. 2007. The evolving paradigm for blood cell-endothelial cell interactions in the cerebral microcirculation. Microcirculation 14:667-81.
22. Geiser T, Buck F, Meyer BJ, Bassetti C, Haeberli A, Gugger M. 2002. In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome. Respiration 69:229-34.
23. Greenberg H, Ye X, Wilson D, Htoo AK, Hendersen T, Liu SF. 2006. Chronic intermittent hypoxia activates nuclear factor-kappaB in cardiovascular tissues in vivo. Biochem Biophys Res Commun 343:591-6.
24. Hoffstein V, Herridge M, Mateika S, Redline S, Strohl KP. 1994. Hematocrit levels in sleep apnea. Chest 106:787-91.
25. Hotamisligil GS. 2006. Inflammation and metabolic disorders. Nature 444:860-67.
26. Htoo AK, Greenberg H, Tongia S, Chen G, Henderson T, Wilson D, Liu SF. 2006. Activation of nuclear factor kappaB in obstructive sleep apnea: a pathway leading to systemic inflammation. Sleep Breath 10:43-50.
27. Hui DS, Ko FW, Fok JP, Chan MC, Li TS, Tomlinson B, Cheng G. 2004. The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome. Chest 125:1768-75.
28. Ip MS, Lam B, Chan LY, Zheng L, Tsang KW, Fung PC, Lam WK. 2000. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 162:2166-71.
29. Itzhaki S, Dorchin H, Clark G, Lavie L, Lavie P, Pillar G. 2007. The effects of 1-year treatment with a herbst mandibular advancement splint on obstructive sleep apnea, oxidative stress, and endothelial function. Chest 131:740-9.
30. Jelic S, Padeletti M, Kawut SM, Higgins C, Canfield SM, Onat D, Colombo PC, Basner RC, Factor P, Lejemtel TH. 2008. Inflammation oxidative stress, and repair capacity of the vascular endothelium in obstructive sleep apnea. Circulation 117:2270-8.
31. Jolly SR, Kane WJ, Hook BG, Abrams GD, Kunkel SL, Lucchesi BR. 1986. Reduction of myocardial infarct size by neutrophil depletion: effect of duration of occlusion. Am Heart J 112:682-90.
32. Kaynak D, Goksan B, Kaynak H, Degirmenci N, Daglioglu S. 2003. Is there a link between the severity of sleep-disordered breathing and atherosclerotic disease of the carotid arteries? Eur J Neurol 10:487-93.
33. Kesler A, Yatziv Y, Shapira I, Berliner S, Assayag EB. 2006. Increased red blood cell aggregation in patients with idiopathic intracranial hypertension. A hitherto unexplored pathophysiological pathway. Thromb Haemost 96:483-7.
34. Kin H, Wang NP, Halkos ME, Kerendi F, Guyton RA, Zhao ZQ. 2006. Neutrophil depletion reduces myocardial apoptosis and attenuates NFkappaB activation/TNFalpha release after ischemia and reperfusion. J Surg Res 135:170-8.
35. Kopelman PG. 2000. Obesity as a medical problem. Nature 404:635-43.
36. Lam JC, Ip MS. 2007. An update on obstructive sleep apnea and the metabolic syndrome. Curr Opin Pulm Med 13:484-89.
37. Lassègue B, Griendling KK. 2004. Reactive oxygen species in hypertension. An update. Am J Hypertens 17:852-60.
38. Lattimore JD, Wilcox I, Nakhla S, Langenfeld M, Jessup W, Celermajer DS. 2005. Repetitive hypoxia increases lipid loading in human macrophages - a potentially atherogenic effect. Atherosclerosis 179:255-9.
39. Lavie L, Dyugovskaya L, Lavie P. 2005a. Sleep apnea related intermittent hypoxia and atherogenesis: adhesion molecules and monocytes/endothelial cells interactions. Atherosclerosis 183:183-4.
40. Lavie L, Hefetz A, Luboshitzky R, Lavie P. 2003. Plasma levels of nitric oxide and L-arginine in sleep apnea patients: effects of nCPAP treatment. J Mol Neurosci 21:57-63.
41. Lavie L, Lavie P. 2006. Ischemic preconditioning as a possible explanation for the age decline relative mortality in sleep apnea. Med Hypotheses 66:1069-73.
42. Lavie L. 2003. Obstructive sleep apnea syndrome - an oxidative stress disorder. Sleep Med Rev 7:35-51.
43. Lavie L. 2004. Sleep apnea syndrome, endothelial dysfunction, and cardiovascular morbidity. Sleep 27:1053-5.
44. Lavie L. 2005. Sleep-disordered breathing and cerebrovascular disease: a mechanistic approach. Neurol Clin 23:1059-75.
45. Lavie L. 2008. Intermittent hypoxia: the culprit of oxidative stress, vascular inflammation and dyslipidemia in obstructive sleep apnea. Expert Rev Resp Med 2:75-84.
46. Lavie P, Herer P, Hoffstein V. 2000. Obstructive sleep apnea syndrome as a risk factor for hypertension: population study. BMJ 320:479-82.
47. Lavie P, Herer P, Peled R, Berger I, Yoffe N, Zomer J, Rubin AH. 1995. Mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep 18:149-57.
48. Lavie P, Lavie L, Herer P. 2005b. All-cause mortality in males with sleep apnea syndrome: declining mortality rates with age. Eur Respir J 25:514-20.
49. Lavie P. 2007. Mortality in sleep apnea syndrome: review of the evidence. Eur Respir Rev 16:203-10.
50. Libby P. 2002. Inflammation in atherosclerosis. Nature. 420:868-74.
51. Libby P. 2007. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev 65(12 Pt 2):S140-6.
52. Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, Frye RL, Weyand CM. 2000. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 101:2883-8.
53. Madjdpour C, Jewell UR, Kneller S, Ziegler U, Schwendener R, Booy C, Kläusli L, Pasch T, Schimmer RC, Beck-Schimmer B. 2003. Decreased alveolar oxygen induces lung inflammation. Am J Physiol Lung Cell Mol Physiol 284:L360-7.
54. Marin JM, Carrizo SJ, Vicente E, Agusti AG. 2005. Long-term cardiovascular outcomes in men with obstructive sleep apnea-hypopnea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046-53.
55. Marti S, Sampol G, Muñoz X, Torres F, Roca A, Lloberes P, Sagalés T, Quesada P, Morell F. 2002. Mortality in severe sleep apnea/hypopnea syndrome patients: impact of treatment. Eur Respir J 20:1511-18.
56. Marx N, Imhof A, Froehlich J, Siam L, Ittner J, Wierse G, Schmidt A, Maerz W, Hombach V, Koenig W. 2003. Effect of rosiglitazone treatment on soluble CD40L in patients with type 2 diabetes and coronary artery disease. Circulation 107:1954-7.
57. McArdle N, Hillman D, Beilin L, Watts G. 2007. Metabolic risk factors for vascular disease in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med 175:190-5.
58. McDonald PP. 2004. Transcriptional regulation in neutrophils: teaching old cells new tricks. Adv Immunol 82:1-48.
59. McNicholas WT, Bonsigore MR and Management Committee of EU COST ACTION B26. 2007. Sleep apnea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities. Eur Respir J 29:156-78.
60. Meigs JB, Larson MG, Fox CS, Keaney JF Jr, Vasan RS, Benjamin EJ. 2007. Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study. Diabetes Care 30:2529-35.
61. Meslier N, Gagnadoux F, Giraud P, Person C, Ouksel H, Urban T, Racineux JL. 2003. Impaired glucose-insulin metabolism in males with obstructive sleep apnea syndrome. Eur Respir J 22:156-60.
62. Minoguchi K, Yokoe T, Tazaki T, Minoguchi H, Oda N, Tanaka A, Yamamoto M, Ohta S, O'Donnell CP, Adachi M. 2007. Silent brain infarction and platelet activation in obstructive sleep apnea. Am J Respir Crit Care Med 175:612-7.
63. Minoguchi K, Yokoe T, Tazaki T, Minoguchi H, Tanaka A, Oda N, Okada S, Ohta S, Naito H, Adachi M. 2005. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 172:625-30.
64. Mooe T, Rabben T, Wiklund U, Franklin KA, Eriksson P. 1996. Sleep-disordered breathing in men with coronary artery disease. Chest 109:659-63.
65. Nagahama H, Soejima M, Uenomachi H, Higashi Y, Yotsumoto K, Samukawa T, Arima T. 2004. Pulse wave velocity as an indicator of atherosclerosis in obstructive sleep apnea syndrome patients. Intern Med 43:184-8.
66. Naruko T, Ueda M, Haze K, van der Wal AC, van der Loos CM, Itoh A, Komatsu R, Ikura Y, Ogami M, Shimada Y, et al. 2002. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 106:2894-900.
67. Newman AB, Nieto FJ, Guidry U, Lind BK, Redline S, Pickering TG, Quan SF. Sleep Heart Health Study Research Group. 2001. Sleep Heart Health Study Research Group. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 154:50-59.
68. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D'Agostino RB, Newman AB, Lebowitz MD, Pickering TG. 2000. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283:1829-36.
69. Nobili L, Schiavi G, Bozano E, De Carli F, Ferrillo F, Nobili F. 2000. Morning increase of whole blood viscosity in obstructive sleep apnea syndrome. Clin Hemorheol Microcirc 22:21-7.
70. Ohga E, Nagase T, Tomita T, Teramoto S, Matsuse T, Katayama H, Ouchi Y. 1999. Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 87:10-4.
71. Packard RR, Libby P. 2008. Inflammation in atherosclerosis: from vascular biology to biomarker discovery and risk prediction. Clin Chem 54:24-38.
72. Panés J, Granger DN. 1998. Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease. Gastroenterology 114:1066-90.
73. Peker Y, Kraiczi H, Hedner J, Löth S, Johansson A, Bende M. 1999. An independent association between obstructive sleep apnea and coronary artery disease. Eur Respir J 14:179-84.
74. Peled N, Kassirer M, Kramer MR, Rogowski O, Shlomi D, Fox B, Berliner AS, Shitrit D. 2008. Increased erythrocyte adhesiveness and aggregation in obstructive sleep apnea syndrome. Thromb Res 121:631-6.
75. Peppard PE, Young T, Palta M, Skatrud J. 2000. Prospective study of the association between sleep disordered breathing and hypertension. N Engl J Med 342:1738-84.
76. Punjabi NM. 2008. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 5:136-43.
77. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. 2002. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165:677-82.
78. Reichmuth KJ, Austin D, Skatrud JB, Young T. 2005. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 172:1590-95.
79. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. 2000. Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 101:2149-53.
80. Rotstein R, Landau T, Twig A, Rubinstein A, Koffler M, Justo D, Constantiner D, Zeltser D, Shapira I, Mardi T, et al. 2002. The erythrocyte adhesiveness/aggregation test (EAAT). A new biomarker to reveal the presence of low grade subclinical smoldering inflammation in individuals with atherosclerotic risk factors. Atherosclerosis 165:343-51.
81. Rudich A, Tirosh A, Potashnik R, Hemi R, Kanety H, Bashan N. 1998. Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes. Diabetes 47:1562-9.
82. Ryan S, McNicholas WT, Taylor CT. 2007. A critical role for p38 map kinase in NF-kappaB signalign during intermittent hypoxia/reoxygenation. Biochem Biophys Res Commun 355:728-33.
83. Ryan S, Taylor CT, McNicholas WT. 2005. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112:2660-7.
84. Samocha-Bonet D, Ben-Ami R, Shapira I, Shenkerman G, Abu-Abeid S, Stern N, Mardi T, Tulchinski T, Deutsch V, Yedgar S, et al. 2004. Flow-resistant red blood cell aggregation in morbid obesity. Int J Obes Relat Metab Disord 28:1528-34.
85. Schultz A, Lavie L, Hochberg I, Beyar R, Stone T, Skorecki K, Lavie P, Roguin A, Levy AP. 1999. Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation 100:547-52.
86. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, Seeger W, Grimminger F. 2000a. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162:566-70.
87. Schulz R, Schmidt D, Blum A, Lopes-Ribeiro X, Lucke C, Mayer K, Olschewski H, Seeger W, Grimminger F. 2000b. Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnea: response to CPAP therapy. Thorax 55:1046-51.
88. Shamsuzzaman AS, Gersh BJ, Somers VK. 2003. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 290:1906-14.
89. Smith PL, Gold AR, Meyers DA, Haponik EF, Bleecker ER. 1985. Weight loss in mildly to moderately obese patients with obstructive sleep apnea. Ann Intern Med 103(Pt 1):850-55.
90. Smith R, Ronald J, Delaive K, Walld R, Manfreda J, Kryger MH. 2002. What are obstructive sleep apnea patients being treated for prior to this diagnosis? Chest 121:164-72.
91. Song L, Leung C, Schindler C. 2001. Lymphocytes are important in early atherosclerosis. J Clin Invest 108:251-9.
92. Stokes KY, Granger DN. 2005. Hypercholesterolemia: its impact on ischemia-reperfusion injury. Expert Rev Cardiovasc Ther 3:1061-70.
93. Suzuki YJ, Jain V, Park AM, Day RM. 2006. Oxidative stress and oxidant signalign in obstructive sleep apnea and associated cardiovascular diseases. Free Radic Biol Med 40:1683-92.
94. Tachibana N, Ayas NT, White DP. 2005. A quantitative assessment of sleep laboratory activity in the United States. J Clin Sleep Med 1:23-6.
95. Ursavaş A, Karadaǧ M, Rodoplu E, Yilmaztepe A, Oral HB, Gözü RO. 2007. Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome. Respiration 74:525-32.
96. Vanderlaan PA, Reardon CA. 2005. Thematic review series: the immune system and atherogenesis. The unusual suspects:an overview of the minor leukocyte populations in atherosclerosis. J Lipid Res 46:829-38.
97. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A, Chrousos GP. 2000. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 85:1151-8.
98. Vinten-Johansen J. 2004. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res 61:481-97.
99. von der Thüsen JH, Kuiper J, van Berkel TJ, Biessen EA. 2003. Interleukins in atherosclerosis: molecular pathways and therapeutic potential. Pharmacol Rev 55:133-66.
100. Wisse BE, Kim F, Schwartz MW. 2007. Physiology. An integrative view of obesity. Science 318:928-9.
101. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. 2005. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 353:2034-41.
102. Yamauchi M, Tamaki S, Tomoda K, Yoshikawa M, Fukuoka A, Makinodan K, Koyama N, Suzuki T, Kimura H. 2006. Evidence for activation of nuclear factor kappaB in obstructive sleep apnea. Sleep Breath 10:189-93.
103. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. 1993. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230-5.
104. Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B, Skatrud J. 1997. Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 157:1746-52.
105. Young T, Peppard PE, Gottlieb DJ. 2002a. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165:1217-39.
106. Young T, Shahar E, Nieto FJ, Redline S, Newman AB, Gottlieb DJ, Walsleben JA, Finn L, Enright P, Samet JM. Sleep Heart Health Study Research Group. 2002b. Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 162:893-900.
107. Zamarrón-Sanz C, Ricoy-Galbaldon J, Gude-Sampedro F, Riveiro-Riveiro A. 2006. Plasma levels of vascular endothelial markers in obstructive sleep apnea. Arch Med Res 37:552-5.
108. Zarbock A, Polanowska-Grabowska RK, Ley K. 2007. Platelet-neutrophil- interactions: linking hemostasis and inflammation. Blood Rev 21:99-111.
109. Zidar N, Jeruc J, Balazic J, Stajer D. 2005. Neutrophils in human myocardial infarction with rupture of the free wall. Cardiovasc Pathol 14:247-50.